Feasibility study of a combined insulin‐delivery and glucose sensor system worn over 7 days in persons with type 1 diabetes
This human feasibility study supports the potential of CGM-IS use for up to 7 days with a mean survival of over 6 days. However, our data indicate that the durability of insulin delivery and sensor refinement are required prior to commercialisation.
Authors
- Jennifer Ngan
- Varuni Obeyesekere
- Hannah Cunningham (ORCID: https://orcid.org/0009-0005-1263-3344)
- Emma Netzer
- Katharine Barnard‐Kelly (ORCID: https://orcid.org/0000-0002-3888-3123)
- Katrin Brown
- Hanna Jones
- David Norman O'Neal (ORCID: https://orcid.org/0000-0002-0870-4032)
- Thomas L. Seidl
- Ralph Dutt‐Ballerstadt (ORCID: https://orcid.org/0000-0003-3046-4335)
- Yee Wen Kong (ORCID: https://orcid.org/0000-0002-7099-8983)
- Solomon Reid
- Huanping Wu
- Steve Flint
- John Apostolopoulos
Institutions
- Baker Heart and Diabetes Institute (AU)
- The University of Melbourne (AU)
- Pacific Environment (US)
- St Vincent's Hospital Melbourne (AU)
- University of Portsmouth (GB)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-11-25
- DOI
- https://doi.org/10.1111/dom.70331
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00